- Stage
- In committee
- Started in
- House
- Sponsors
- 2
- Latest action
- Jun 12, 2025
What it does
The RAPID Reserve Act would require the Secretary of Health and Human Services to establish contracts or cooperative agreements with eligible entities to maintain a six-month reserve of critical drugs and their active pharmaceutical ingredients, regularly replenished with recently manufactured supplies, to prevent disruptions during shortages or public health emergencies. Eligible entities—including drug manufacturers, API producers, and distributors with strong manufacturing records and domestic or OECD-country facilities—must agree to produce drugs or ingredients as directed by the Secretary, transfer reserves when needed, and allow federal allocation during emergencies. The bill…
No official summary is available here. This one was written by AI from the bill’s text.
Where it stands
Introduced (Done)
Committee (Current step)
Floor (Not started)
Law (Not started)
What moved
Who is involved
Sponsors
The lawmakers who put their names on it, lead sponsors first.
In the news
Reporting that may mention this subject. Possible matches are labeled.
Loading coverage…
Where it goes next
While a bill can still move, the questions are about people and money.